Their molecular assay for soil and seed-borne pathogens enables affordable detection of hundreds of pathogens and beneficial organisms simultaneously. Their assay is based on genetic sequencing technology, enabling strain-specific identification and quantitation. They use artificial intelligence techniques used in fraud detection and data science to identify microbes and genetic mutations that cause or protect from disease, enabling data-driven insights into soil health and methods to increase crop quality, including yield and shelf life.
Some data provided by Crunchbase
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Trace Genomics or any companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.
To learn more about whether you're eligible, typical investment size, company valuation, and share price, request access here.